Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

CORRECTION: MANDATORY NOTIFICATION OF TRADE

06.05.2022

MANDATORY NOTIFICATION OF TRADE

06.05.2022

FIRST QUARTER 2022 FINANCIAL REPORT

06.05.2022

APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE

29.04.2022

COMPLETED ANNUAL GENERAL MEETING

29.04.2022

NOTICE OF ANNUAL GENERAL MEETING 2022

08.04.2022

HBC ANNUAL REPORT 2021

25.03.2022

HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE

11.03.2022

HOFSETH BIOCARE SECURES INNOVATION AWARD FOR MEDICAL NUTRITION

08.02.2022

FOURTH QUARTER 2021 FINANCIAL REPORT

04.02.2022

Previous
1
2 3 4
...
30
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies